| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1872-034X.2012.01008.X |
| P698 | PubMed publication ID | 22612669 |
| P50 | author | Tetsuya Hosaka | Q56223851 |
| Norio Akuta | Q87747459 | ||
| Yusuke Kawamura | Q90407021 | ||
| Hitomi Sezaki | Q92198438 | ||
| Kenji Ikeda | Q114433562 | ||
| Hiromitsu Kumada | Q114433568 | ||
| Fumitaka Suzuki | Q114923480 | ||
| Masahiro Kobayashi | Q114923755 | ||
| Yoshiyuki Suzuki | Q114923935 | ||
| Yasuji Arase | Q114924322 | ||
| Satoshi Saito | Q114924602 | ||
| Mariko Kobayashi | Q114924823 | ||
| P2093 | author name string | Naoki Matsumoto | |
| Yuya Seko | |||
| Miharu Hirakawa | |||
| P2860 | cites work | Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 |
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
| Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis | Q28183279 | ||
| Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 | ||
| Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C | Q29619541 | ||
| Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis. | Q30579693 | ||
| Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial | Q42844274 | ||
| Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy | Q42981569 | ||
| Natural human interferon beta plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus and a high viral load | Q42982755 | ||
| Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy. | Q42993815 | ||
| Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 1b and high virus load | Q42997469 | ||
| Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin. | Q42998703 | ||
| Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C. | Q43035294 | ||
| The efficacy of a herbal medicine (Mao-to) in combination with intravenous natural interferon-beta for patients with chronic hepatitis C, genotype 1b and high viral load: a pilot study | Q43039924 | ||
| Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. | Q43040369 | ||
| Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients. | Q43040948 | ||
| A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. | Q44527614 | ||
| Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment | Q44901526 | ||
| Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir. | Q50557485 | ||
| Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. | Q50569792 | ||
| Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C. | Q50577281 | ||
| The efficacy of interferon-beta monotherapy for elderly patients with type C hepatitis of genotype 2. | Q51619721 | ||
| A high-throughput SNP typing system for genome-wide association studies | Q57269468 | ||
| P433 | issue | 10 | |
| P921 | main subject | ribavirin | Q421862 |
| viral load | Q2528140 | ||
| chronic hepatitis C | Q55779873 | ||
| P304 | page(s) | 949-957 | |
| P577 | publication date | 2012-05-21 | |
| P1433 | published in | Hepatology Research | Q15752035 |
| P1476 | title | Efficacy of reduction therapy of natural human β-interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 1b and high viral load | |
| P478 | volume | 42 |
| Q41750179 | Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: A retrospective study using the Japanese Interferon Database. |
| Q47888797 | Efficacy and safety of telaprevir with natural human interferon-β and ribavirin in Japanese chronic hepatitis C patients with depression |
| Q35783876 | Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens |
| Q42249679 | Interferon-α/β for treatment of chronic hepatitis C infection in the era of direct-acting antiviral agents. |
| Q35668734 | Natural interferon-beta treatment for patients with chronic hepatitis C in Japan |
Search more.